載入...
Germline and Somatic Pharmacogenomics to Refine Rectal Cancer Patients Selection for Neo-Adjuvant Chemoradiotherapy
Neoadjuvant chemoradiotherapy (nCRT) followed by radical surgery is the standard of care for patients with Locally Advanced Rectal Cancer (LARC). Current selection for nCRT is based on clinical criteria regardless of any molecular marker. Pharmacogenomics may be a useful strategy to personalize and...
Na minha lista:
| 發表在: | Front Pharmacol |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7311751/ https://ncbi.nlm.nih.gov/pubmed/32625092 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.00897 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|